Sulfate ion

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Sulfate ion
DrugBank Accession Number
DB14546
Background

Not Available

Type
Small Molecule
Groups
Experimental, Investigational
Structure
Weight
Average: 96.063
Monoisotopic: 95.951729178
Chemical Formula
O4S
Synonyms
  • Sulfate
  • Sulfate dianion
  • Sulfate(2-)
  • Sulfuric acid ion(2-)

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of dehydration can be increased when Acetazolamide is combined with Sulfate ion.
AclidiniumThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Aclidinium.
AlfentanilThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Sulfate ion is combined with Alloin.
AlmasilateThe therapeutic efficacy of Sulfate ion can be decreased when used in combination with Almasilate.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Loa Freedom SCapsule100 g/1001OralLOA BIO INC.2020-11-09Not applicableUS flag
Loa New-freedom SCapsule100 g/1001OralCO LTD JUNG MIN2021-04-25Not applicableUS flag
New-freedom SCapsule100 g/1001OralCO LTD JUNG MIN2021-04-25Not applicableUS flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalTELOM-X GENE Co., Ltd.2017-07-01Not applicableUS flag
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalNano Bio Tech Co.,Ltd2017-07-01Not applicableUS flag
Telom-X-geneSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalTELOM-X GENE Co., Ltd.2017-07-01Not applicableUS flag
VAMIN 14 IV AMINOASIT SOLÜSYONU, 500 MLSulfate ion (8 mmol/L) + Acetate (135 mmol/L) + Alanine (12 g/L) + Arginine (8.4 g/L) + Aspartic acid (2.5 g/L) + Calcium (5 mmol/L) + Chloride ion (100 mmol/L) + Cysteine (420 mg/L) + Glutamic acid (4.2 g/L) + Glycine (5.9 g/L) + Histidine (5.1 g/L) + Isoleucine (4.2 g/L) + Leucine (5.9 g/L) + Lysine (6.8 g/L) + Magnesium (8 mmol/L) + Methionine (4.2 g/L) + Phenylalanine (5.9 g/L) + Potassium (50 mmol/L) + Proline (5.1 g/L) + Serine (3.4 g/L) + Sodium cation (100 mmol/L) + Threonine (4.2 g/L) + Tryptophan (1.4 g/L) + Tyrosine (170 mg/L) + Valine (5.5 g/L)SolutionIntravenousFRESENİUS KABİ İLAÇ SAN. VE TİC. LTD. ŞTİ.2020-08-142019-10-12Turkey flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Loa Freedom SSulfate ion (100 g/1001)CapsuleOralLOA BIO INC.2020-11-09Not applicableUS flag
Loa New-freedom SSulfate ion (100 g/1001)CapsuleOralCO LTD JUNG MIN2021-04-25Not applicableUS flag
New-freedom SSulfate ion (100 g/1001)CapsuleOralCO LTD JUNG MIN2021-04-25Not applicableUS flag
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalTELOM-X GENE Co., Ltd.2017-07-01Not applicableUS flag
RurinaSulfate ion (3.6 g/1L) + Chloride ion (0.11 g/1L) + Potassium cation (0.25 g/1L)LiquidTopicalNano Bio Tech Co.,Ltd2017-07-01Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
7IS9N8KPMG
CAS number
14808-79-8
InChI Key
QAOWNCQODCNURD-UHFFFAOYSA-L
InChI
InChI=1S/H2O4S/c1-5(2,3)4/h(H2,1,2,3,4)/p-2
IUPAC Name
sulfate
SMILES
[O-]S([O-])(=O)=O

References

General References
Not Available
Human Metabolome Database
HMDB0001448
ChemSpider
1085
BindingDB
26992
RxNav
1426598
ChEBI
16189
PDBe Ligand
SO4
Wikipedia
Sulfate
PDB Entries
101m / 102m / 103m / 104m / 105m / 106m / 107m / 108m / 109m / 110m
show 24845 more

Clinical Trials

Clinical Trials

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral100 g/1001
LiquidTopical
SolutionIntravenous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-0.84Chemaxon
pKa (Strongest Acidic)-3Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area80.26 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity11.53 m3·mol-1Chemaxon
Polarizability5.81 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-103.6056324
predicted
DarkChem Lite v0.1.0
[M-H]-106.555504
predicted
DeepCCS 1.0 (2019)
[M-H]-103.6056324
predicted
DarkChem Lite v0.1.0
[M-H]-106.555504
predicted
DeepCCS 1.0 (2019)
[M+H]+109.33417
predicted
DeepCCS 1.0 (2019)
[M+H]+109.33417
predicted
DeepCCS 1.0 (2019)
[M+Na]+117.68899
predicted
DeepCCS 1.0 (2019)
[M+Na]+117.68899
predicted
DeepCCS 1.0 (2019)

Drug created at July 12, 2018 21:40 / Updated at June 12, 2020 16:53